Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
Chu Y, Nayyar G, Tian M, Lee DA, Ozkaynak MF, Ayala-Cuesta J, Klose K, Foley K, Mendelowitz AS, Luo W, Liao Y, Ayello J, Behbehani GK, Riddell S, Cripe T, Cairo MS.
Chu Y, et al.
Mol Ther Oncol. 2024 May 24;32(2):200820. doi: 10.1016/j.omton.2024.200820. eCollection 2024 Jun 20.
Mol Ther Oncol. 2024.
PMID: 38933492
Free PMC article.